The COL18A1 gene helps make collagen XVIII, a support protein in thin tissue layers that help hold parts of the eye, brain, and other organs together. If the COL18A1 gene does not work properly, these tissues may not develop or stay stable as they should. Some people with pathogenic variants in the COL18A1 gene have Knobloch syndrome, which is linked to high myopia, retinal detachment, and an opening or soft spot at the back of the skull. This gene plays an important role in controlling blood vessel growth through a piece of the protein called endostatin.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
COL18A1Gene function
What if the gene works
The COL18A1 gene helps make collagen XVIII, a support protein in thin tissue layers that line organs and blood vessels. It also helps normal eye development and guides blood vessel growth.
Risk
What if the gene does not work
More disruptive variants in the COL18A1 gene can cause Knobloch syndrome, with early severe vision problems and a skull opening at the back of the head. Milder variants may affect when symptoms begin and how strongly they appear.
Treatment
What does that mean for your treatment
No COL18A1-specific treatment or drug-choice approach is currently established. The COL18A1 gene is being studied through endostatin, a protein fragment linked to blood vessel growth, as a possible biomarker and treatment target in cancer and eye disease research.
Conditions associated with COL18A1
Gene function
What if the gene works
Your body uses the COL18A1 gene to make collagen XVIII, a protein that becomes part of the thin support layers beneath many cells. These layers help tissues stay organized, stable, and well supported. Understanding what the COL18A1 gene does in the body helps explain how organs keep their shape and boundaries during everyday wear and repair.
The COL18A1 gene helps build basement membranes, the thin sheets that support cells in many organs. This gives tissues a steady foundation and helps nearby structures stay in place.
Collagen XVIII helps basement membranes act as clear borders between different tissue layers. This supports normal filtering and separation in places such as blood vessels and other delicate tissues.
Its protein helps cells attach to their surrounding support material. This steady attachment helps cells keep their position and work in an organized way.
Part of the collagen XVIII protein can also be released as a smaller piece called endostatin. This helps fine tune signals involved in blood vessel growth and tissue upkeep.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COL18A1 gene often lead to a shortened or missing collagen XVIII protein, while milder changes may mainly alter folding or reduce how much protein reaches basement membranes, the thin support layers around cells. This helps explain how variants in the COL18A1 gene affect protein function. More disruptive variants often leave little to no working protein and can be linked to earlier or more marked features of Knobloch syndrome, while milder variants may preserve some activity.
How variants are linked to conditions
Pathogenic variants in the COL18A1 gene cause Knobloch syndrome, a rare inherited condition linked to severe nearsightedness, retinal problems that can lead to vision loss, and skull changes near the back of the head. Many people first notice eye symptoms, often in childhood. Information on conditions linked to the COL18A1 gene mainly centers on Knobloch syndrome. Finding a disease causing variant in both copies of the gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For COL18A1, risk is mainly shaped by family genetics rather than lifestyle. A child’s chance is higher when both parents carry a harmful COL18A1 variant, and this can be more likely in families where the parents are biologically related; beyond that, there is not broadly confirmed evidence that other factors clearly increase or reduce risk.
Inheritance of COL18A1 variants
COL18A1-related conditions are most often inherited in an autosomal recessive pattern. This means a person usually inherits one COL18A1 gene variant from each parent. Parents who each carry one variant are often unaffected, but with each pregnancy there is a 25% chance of having a child with the condition, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. In practical terms, COL18A1 inheritance usually means the condition appears only when both copies of the gene are changed.
What does my COL18A1 result mean for my family?
For COL18A1, family impact is usually discussed in the setting of an inherited condition called Knobloch syndrome, which most often runs in a recessive pattern. This means parents are often healthy carriers, and brothers or sisters may also be affected or may be carriers. Close relatives may want to learn whether the same COL18A1 change is present in their family, especially when there is a history of severe eye problems or an opening in the back of the skull.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the COL18A1 gene linked with Knobloch syndrome usually uses a blood or saliva sample. The lab reads your DNA to check for changes in the COL18A1 gene, and the report may find a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the COL18A1 gene may be worth considering when someone has signs of Knobloch syndrome, such as severe vision problems from early life, retinal detachment, or certain skull or brain differences. It can also help when a close relative has a known COL18A1 variant or this condition runs in the family.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, though how much it reveals depends on the condition and the type of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other aspects of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medicines. By studying the connection between genes and medications, it helps explain why a treatment may work differently from one person to another. For many drugs, genes can influence both how strongly a medicine works and how the body processes it. This information can support more informed treatment choices that are tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the COL18A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or your overall health are best discussed with your doctor.
History
First described in the scientific literature as part of early genetics, the COL18A1 gene drew attention during work on inherited eye and brain findings later linked to Knobloch syndrome. In the 1990s, researchers mapped the gene to chromosome 21 and connected harmful variants with families who shared this pattern across generations. From these first observations, research expanded steadily. Interest in the COL18A1 gene also grew when scientists identified endostatin, a fragment made from the same protein, during a period of intense research on blood vessel growth and cancer biology. Over time, descriptions became more precise as different forms of the gene’s protein product were recognized in human tissues. These historical steps shaped today’s understanding of the COL18A1 gene in both rare inherited conditions and broader biomedical research.